{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:02:03Z","timestamp":1759971723590,"version":"build-2065373602"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,2,20]],"date-time":"2018-02-20T00:00:00Z","timestamp":1519084800000},"content-version":"am","delay-in-days":384,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007917","name":"Agricultural Research Service","doi-asserted-by":"crossref","award":["58-6408-2-0009"],"award-info":[{"award-number":["58-6408-2-0009"]}],"id":[{"id":"10.13039\/100007917","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ethnopharmacology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.jep.2016.07.069","type":"journal-article","created":{"date-parts":[[2016,7,27]],"date-time":"2016-07-27T03:39:27Z","timestamp":1469590767000},"page":"211-217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Utilizing Ayurvedic literature for the identification of novel phytochemical inhibitors of botulinum neurotoxin A"],"prefix":"10.1016","volume":"197","author":[{"given":"Chinni","family":"Yalamanchili","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vamshi K.","family":"Manda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amar G.","family":"Chittiboyina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca L.","family":"Guernieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"William A.","family":"Harrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert P.","family":"Webb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonard A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikhlas A.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jep.2016.07.069_bib1","first-page":"265","article-title":"Standardization of Fennel (Foeniculum vulgare), its oleoresin and marketed Ayurvedic dosage forms","volume":"3","author":"Anubhuti","year":"2011","journal-title":"Int J. Pharm. Sci. Drug Res"},{"issue":"8","key":"10.1016\/j.jep.2016.07.069_bib2","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jama.285.8.1059","article-title":"Botulinum toxin as a biological weapon: medical and public health management","volume":"285","author":"Arnon","year":"2001","journal-title":"J. Am. Med. Assoc."},{"issue":"25","key":"10.1016\/j.jep.2016.07.069_bib3","first-page":"2740","article-title":"Acorus calamus: an overview","volume":"4","author":"Balakumbahan","year":"2010","journal-title":"J. Med. Plants Res."},{"issue":"1","key":"10.1016\/j.jep.2016.07.069_bib4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4103\/0253-7613.62405","article-title":"Immunosuppressive properties of Pluchea lanceolata leaves","volume":"42","author":"Bhagwat","year":"2010","journal-title":"Indian J. Pharmacol."},{"issue":"7019","key":"10.1016\/j.jep.2016.07.069_bib5","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/nature03123","article-title":"Substrate recognition strategy for botulinum neurotoxin serotype A","volume":"432","author":"Breidenbach","year":"2004","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.jep.2016.07.069_bib6","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1021\/jm4012164","article-title":"Identification of clinically viable quinolinol inhibitors of botulinum neurotoxin A light chain","volume":"57","author":"Caglic","year":"2014","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.jep.2016.07.069_bib7","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1021\/ml200312s","article-title":"Fungal bis-naphthopyrones as inhibitors of botulinum neurotoxin serotype A","volume":"3","author":"Cardellina","year":"2012","journal-title":"ACS Med. Chem. Lett."},{"issue":"3","key":"10.1016\/j.jep.2016.07.069_bib8","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/phar.1196","article-title":"Abo-, inco-, ona-, and rima-botulinum toxins in clinical therapy: a primer","volume":"33","author":"Chen","year":"2013","journal-title":"Pharmacotherapy"},{"issue":"6","key":"10.1016\/j.jep.2016.07.069_bib9","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1016\/j.bbagen.2013.02.008","article-title":"Natural products: a continuing source of novel drug leads","volume":"1830","author":"Cragg","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jep.2016.07.069_bib10","unstructured":"CRCPress, 2012. Dictionary of Natural Products on DVD."},{"key":"10.1016\/j.jep.2016.07.069_bib11","unstructured":"Dash, V.B., Kashyap, L., 1996. Diagnosis and treatment of diseases in Ayurveda. Based on Ayurveda saukhyam of Todadarananda Series No. 5, Part 3, 227\u2013483."},{"issue":"5","key":"10.1016\/j.jep.2016.07.069_bib12","doi-asserted-by":"crossref","first-page":"489","DOI":"10.4103\/IJMR.2010_132_05_489","article-title":"Botulinum toxin: bioweapon & magic drug","volume":"132","author":"Dhaked","year":"2010","journal-title":"Indian J. Med. Res."},{"issue":"4","key":"10.1016\/j.jep.2016.07.069_bib13","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1089\/jmf.2006.129","article-title":"Evaluation of in vitro antioxidant activity of Sida rhombifolia (L.) ssp. retusa (L.)","volume":"10","author":"Dhalwal","year":"2007","journal-title":"J. Med. Food"},{"issue":"6","key":"10.1016\/j.jep.2016.07.069_bib14","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1021\/ml100074s","article-title":"Identification of a natural product antagonist against the botulinum neurotoxin light chain protease","volume":"1","author":"Eubanks","year":"2010","journal-title":"ACS Med. Chem. Lett."},{"issue":"Suppl. 1","key":"10.1016\/j.jep.2016.07.069_bib15","first-page":"S69","article-title":"The value of plants used in traditional medicine for drug discovery","volume":"109","author":"Fabricant","year":"2001","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.jep.2016.07.069_bib16","unstructured":"FDA, 1968. Substances Generally Prohibited From Direct Addition or Use as Human Food: Calamus and its derivatives. In: Administration, F.A.D. (Ed.), Code of Federal Regulations. Title 21, Chapter I, Subchapter B, Part 189"},{"issue":"1","key":"10.1016\/j.jep.2016.07.069_bib17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0378-8741(02)00168-X","article-title":"Investigations into the immunomodulatory activity of Argyreia speciosa","volume":"84","author":"Gokhale","year":"2003","journal-title":"J. Ethnopharmacol."},{"issue":"28","key":"10.1016\/j.jep.2016.07.069_bib18","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s10822-014-9758-7","article-title":"Structural insight into exosite binding and discovery of novel exosite inhibitors of botulinum neurotoxin serotype A through in silico screening","volume":"7","author":"Hu","year":"2014","journal-title":"J. Comput.-Aided Mol. Des."},{"issue":"2","key":"10.1016\/j.jep.2016.07.069_bib19","first-page":"23","article-title":"Sida cordifolia (Linn) \u2013 an overview","volume":"1","author":"Jain","year":"2011","journal-title":"J. Appl. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.jep.2016.07.069_bib20","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0041-0101(03)00042-4","article-title":"Expression, purification, and efficacy of the type A botulinum neurotoxin catalytic domain fused to two translocation domain variants","volume":"41","author":"Jensen","year":"2003","journal-title":"Toxicon"},{"issue":"1","key":"10.1016\/j.jep.2016.07.069_bib21","first-page":"64","article-title":"Zingiber officinale: evaluation of its nootropic effect in mice","volume":"3","author":"Joshi","year":"2006","journal-title":"Afr. J. Tradit. Complement. Altern. Med."},{"issue":"6","key":"10.1016\/j.jep.2016.07.069_bib22","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1159\/000210545","article-title":"Botulinum neurotoxin: the ugly duckling","volume":"61","author":"Koussoulakos","year":"2009","journal-title":"Eur. Neurol."},{"issue":"2","key":"10.1016\/j.jep.2016.07.069_bib23","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.jep.2010.12.019","article-title":"Gastric antisecretory and antiulcer activities of Cedrus deodara (Roxb.) Loud. in Wistar rats","volume":"134","author":"Kumar","year":"2011","journal-title":"J. Ethnopharmacol."},{"issue":"7","key":"10.1016\/j.jep.2016.07.069_bib24","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2174\/1568026615666150309150338","article-title":"Recent developments with metalloprotease inhibitor class of drug candidates for botulinum neurotoxins","volume":"15","author":"Kumar","year":"2015","journal-title":"Curr. Top. Med. Chem."},{"issue":"27","key":"10.1016\/j.jep.2016.07.069_bib25","doi-asserted-by":"crossref","first-page":"18883","DOI":"10.1074\/jbc.M801240200","article-title":"Structure- and substrate-based inhibitor design for clostridium botulinum neurotoxin serotype A","volume":"283","author":"Kumaran","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.jep.2016.07.069_bib26","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/2338","article-title":"Crystal structure of botulinum neurotoxin type A and implications for toxicity","volume":"5","author":"Lacy","year":"1998","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"491","key":"10.1016\/j.jep.2016.07.069_bib27","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.abb.2009.09.008","article-title":"Quinolinol and peptide inhibitors of zinc protease in botulinum neurotoxin A: effects of zinc ion and peptides on inhibition","volume":"1","author":"Lai","year":"2009","journal-title":"Arch. Biochem. Biophys."},{"issue":"4","key":"10.1016\/j.jep.2016.07.069_bib28","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/ddr.20304","article-title":"US Army botulinum neurotoxin (BoNT) medical therapeutics research program: past accomplishments and future directions","volume":"70","author":"Larsen","year":"2009","journal-title":"Drug. Dev. Res."},{"issue":"1","key":"10.1016\/j.jep.2016.07.069_bib29","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3390\/molecules16010202","article-title":"Small molecule inhibitors as countermeasures for botulinum neurotoxin intoxication","volume":"16","author":"Li","year":"2010","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.jep.2016.07.069_bib30","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1177\/1073858414524633","article-title":"More than at the neuromuscular synapse: actions of botulinum neurotoxin A in the central nervous system","volume":"21","author":"Mazzocchio","year":"2015","journal-title":"Neuroscientist"},{"issue":"1","key":"10.1016\/j.jep.2016.07.069_bib31","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1146\/annurev.biochem.051908.125345","article-title":"Botulinum neurotoxin: a marvel of protein design","volume":"79","author":"Montal","year":"2010","journal-title":"Annu. Rev. Biochem."},{"issue":"3","key":"10.1016\/j.jep.2016.07.069_bib32","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1021\/np200906s","article-title":"Natural products as sources of new drugs over the 30 years from 1981 to 2010","volume":"75","author":"Newman","year":"2012","journal-title":"J. Nat. Prod."},{"issue":"15","key":"10.1016\/j.jep.2016.07.069_bib33","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.drudis.2009.05.009","article-title":"Traditional medicine-inspired approaches to drug discovery: can Ayurveda show the way forward?","volume":"14","author":"Patwardhan","year":"2009","journal-title":"Drug Discov. Today"},{"issue":"4","key":"10.1016\/j.jep.2016.07.069_bib34","first-page":"1706","article-title":"Ricinus communis L.\u2014a review","volume":"4","author":"Rana","year":"2012","journal-title":"Int. J. PharmTech Res."},{"issue":"8","key":"10.1016\/j.jep.2016.07.069_bib35","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1128\/AAC.00141-09","article-title":"Identification and biochemical characterization of small-molecule inhibitors of Clostridium botulinum neurotoxin serotype A","volume":"53","author":"Roxas-Duncan","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.jep.2016.07.069_bib36","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1039\/c0cc04078a","article-title":"A cross-over inhibitor of the botulinum neurotoxin light chain B: a natural product implicating an exosite mechanism of action","volume":"47","author":"Salzameda","year":"2011","journal-title":"Chem. Commun."},{"issue":"2","key":"10.1016\/j.jep.2016.07.069_bib37","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1152\/physrev.2000.80.2.717","article-title":"Neurotoxins affecting neuroexocytosis","volume":"80","author":"Schiavo","year":"2000","journal-title":"Physiol. Rev."},{"year":"2015","series-title":"Release 2015-2: Maestro, Version 10.3","author":"Schr\u00f6dinger","key":"10.1016\/j.jep.2016.07.069_bib38"},{"issue":"3","key":"10.1016\/j.jep.2016.07.069_bib39","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.bmc.2013.11.053","article-title":"Synthesis\/biological evaluation of hydroxamic acids and their prodrugs as inhibitors for Botulinum neurotoxin A light chain","volume":"22","author":"Seki","year":"2014","journal-title":"Bioorg. Med. Chem."},{"issue":"6","key":"10.1016\/j.jep.2016.07.069_bib40","doi-asserted-by":"crossref","first-page":"672","DOI":"10.4103\/0253-7613.103237","article-title":"Antiurolithiatic and antioxidant activity of Hordeum vulgare seeds on ethylene glycol-induced urolithiasis in rats","volume":"44","author":"Shah","year":"2012","journal-title":"Indian J. Pharmacol."},{"issue":"9","key":"10.1016\/j.jep.2016.07.069_bib41","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1021\/ja910761y","article-title":"Botulinum neurotoxin A protease: discovery of natural product exosite inhibitors","volume":"132","author":"Silhar","year":"2010","journal-title":"J. Am. Chem. Soc."},{"issue":"5","key":"10.1016\/j.jep.2016.07.069_bib42","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.bmc.2012.12.001","article-title":"Evaluation of adamantane hydroxamates as botulinum neurotoxin inhibitors: synthesis, crystallography, modeling, kinetic and cellular based studies","volume":"21","author":"Silhar","year":"2013","journal-title":"Bioorg. Med. Chem."},{"issue":"5","key":"10.1016\/j.jep.2016.07.069_bib43","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.chembiol.2007.03.014","article-title":"Structures of Clostridium botulinum neurotoxin serotype A light chain complexed with small-molecule inhibitors highlight active-site flexibility","volume":"14","author":"Silvaggi","year":"2007","journal-title":"Chem. Biol."},{"issue":"2","key":"10.1016\/j.jep.2016.07.069_bib44","first-page":"11","article-title":"Clerodendrum serratum: a clinical approach","volume":"2","author":"Singh","year":"2012","journal-title":"J. Appl. Pharm. Sci."},{"issue":"8","key":"10.1016\/j.jep.2016.07.069_bib45","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1086\/444507","article-title":"Botulism","volume":"41","author":"Sobel","year":"2005","journal-title":"Clin. Infect. Dis."},{"issue":"8","key":"10.1016\/j.jep.2016.07.069_bib46","doi-asserted-by":"crossref","first-page":"915","DOI":"10.3109\/13880200903406147","article-title":"Antihyperlipidemic activity of Clitoria ternatea and Vigna mungo in rats","volume":"48","author":"Solanki","year":"2010","journal-title":"Pharm. Biol."},{"issue":"4","key":"10.1016\/j.jep.2016.07.069_bib47","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.fct.2008.12.022","article-title":"Protective effects of Coriandrum sativum extracts on carbon tetrachloride-induced hepatotoxicity in rats","volume":"47","author":"Sreelatha","year":"2009","journal-title":"Food Chem. Toxicol."},{"issue":"2","key":"10.1016\/j.jep.2016.07.069_bib48","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jep.2005.01.055","article-title":"Preliminary pharmacological studies on Piper chaba stem bark","volume":"99","author":"Taufiq-Ur-Rahman","year":"2005","journal-title":"J. Ethnopharmacol."},{"issue":"19","key":"10.1016\/j.jep.2016.07.069_bib49","doi-asserted-by":"crossref","first-page":"4019","DOI":"10.1021\/bi2001483","article-title":"Structural characterization of three novel hydroxamate-based zinc chelating inhibitors of the Clostridium botulinum serotype A neurotoxin light chain metalloprotease reveals a compact binding site resulting from 60\/70 loop flexibility","volume":"50","author":"Thompson","year":"2011","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/j.jep.2016.07.069_bib50","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1124\/jpet.109.156901","article-title":"Capsaicin protects mouse neuromuscular junctions from the neuroparalytic effects of botulinum neurotoxin a","volume":"331","author":"Thyagarajan","year":"2009","journal-title":"J. Pharm. Exp. Ther."},{"issue":"8","key":"10.1016\/j.jep.2016.07.069_bib52","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.neuropharm.2010.02.014","article-title":"Effects of hydroxamate metalloendoprotease inhibitors on botulinum neurotoxin A poisoned mouse neuromuscular junctions","volume":"58","author":"Thyagarajan","year":"2010","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.jep.2016.07.069_bib53","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.toxicon.2012.04.004","article-title":"Capsaicin: a novel antidote against botulinum neurotoxin A","volume":"60","author":"Thyagarajan","year":"2012","journal-title":"Toxicon"},{"issue":"44","key":"10.1016\/j.jep.2016.07.069_bib54","doi-asserted-by":"crossref","first-page":"8360","DOI":"10.1002\/anie.200705531","article-title":"The strange case of the botulinum neurotoxin: using chemistry and biology to modulate the most deadly poison","volume":"47","author":"Willis","year":"2008","journal-title":"Angew. Chem. Int. Ed."},{"issue":"24","key":"10.1016\/j.jep.2016.07.069_bib55","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1056\/NEJMra1114525","article-title":"Guillain\u2013Barr\u00e9 syndrome","volume":"366","author":"Yuki","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.jep.2016.07.069_bib56","doi-asserted-by":"crossref","first-page":"867","DOI":"10.3109\/15563650.2010.535003","article-title":"Botulism, where are we now?","volume":"48","author":"Zhang","year":"2010","journal-title":"Clin. Toxicol."}],"container-title":["Journal of Ethnopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874116305001?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874116305001?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T16:18:04Z","timestamp":1759940284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378874116305001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":55,"alternative-id":["S0378874116305001"],"URL":"https:\/\/doi.org\/10.1016\/j.jep.2016.07.069","relation":{},"ISSN":["0378-8741"],"issn-type":[{"type":"print","value":"0378-8741"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utilizing Ayurvedic literature for the identification of novel phytochemical inhibitors of botulinum neurotoxin A","name":"articletitle","label":"Article Title"},{"value":"Journal of Ethnopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jep.2016.07.069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}